GNOM ETF (Global X Genomics & Biotechnology ETF) is managed by Global X by mirae Asset with $86.7M in net assets. GNOM expense ratio is 0.50%, holding 52 positions across sectors including Health Care, Unknown, Information Technology. Inception date: 2019-04-05.

GNOM performance shows a YTD return of 18.34%. The 1-year return is 70.44% and the 5-year return is -10.38%. GNOM dividend yield stands at 1.15%, paid annually.

GNOM top holdings include Illumina, Inc. (4.5%), Guardant Health, Inc (4.5%), Arrowhead Pharmaceuticals Inc (4.3%), Nvaesrtex Pharmaceuticals Inc (4.1%), LEGEND BIOTECH CORP-ADR (4.1%). View all GNOM holdings, sector breakdown, or dividend history.

GNOM can be compared against other funds using the overlap calculator or side-by-side comparison tool. GNOM alternatives are available via the screener, along with tax-loss harvesting opportunities.